Menu
Back to Journals » OncoTargets and Therapy » Volume 13
RETRACTED ARTICLE: Upregulation of FTX Promotes Osteosarcoma Tumorigenesis by Increasing SOX4 Expression via miR-214-5p
Authors Chen H, Liu T, Ouyang H, Lin S, Zhong H, Zhang H, Yang Y
Received 10 November 2019
Accepted for publication 22 June 2020
Published 23 July 2020 Volume 2020:13 Pages 7125—7136
DOI https://doi.org/10.2147/OTT.S238070
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Geoffrey Pietersz
This paper has been retracted.
Chen H, Liu T, Ouyang H, et al. Onco Targets Ther. 2020;13:7125–7136.
We, the Editors and Publisher of OncoTargets and Therapy, have retracted the published article.
Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As verifying the validity of the published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.